Matthew T. Howard

RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis

Ryan M. Carr, Denis Vorobyev, Terra L. Lasho et al. · Nature Communications · 2021 · 100 citations · Full text

Medicine, Molecular Biology, Oncology +17

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia

Nolwenn Lucas, Matthieu Duchmann, Philippe Rameau et al. · Leukemia · 2019 · 99 citations

Medicine, Hematology, Oncology +16

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor<i>MYD88</i>L265P Mutations

Rebecca L. King, Wilson I. Gonsalves, Stephen M. Ansell et al. · American Journal of Clinical Pathology · 2016 · 55 citations · Full text

Medicine, Hematology, Pathology +12

Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients

Marissa Li, Moritz Binder, Terra L. Lasho et al. · Blood Advances · 2021 · 44 citations · Full text

Medicine, Hematology, Molecular Genetics +17

Follicular Lymphoma of the Spleen

Matthew T. Howard, Scott D. Dufresne, Steven H. Swerdlow et al. · American Journal of Clinical Pathology · 2009 · 39 citations · Full text

Medicine, Hematology, Pathology +17